NEW YORK, May 23, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Biochips Market 2012-2016
TechNavio's analysts forecast the Global Biochips market to grow at a CAGR of 19.1 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing need for high speed diagnosis. The Global Biochips market has also been witnessing the high cost of deployment. However, the increasing outsourcing activities could pose a challenge to the growth of this market.
TechNavio's report, the Global Biochips market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Biochips market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space include Affymetrix Inc., Illumina, Inc., GE Healthcare Ltd. and Agilent Technologies Inc.
Other vendors mentioned in the report are Bio-Rad Laboratories Inc., Biomrieux Sa, Caliper Life Sciences Inc., Cephied Inc., Fluidigm Corp., Life Technologies Corp., Cybrdi Inc., Gamida For Life Group, Origene Technologies Inc., Perkinelmer Inc., Roche Nimblegen Inc., Sigma Aldrich Corp, Isu Abxis Co. Ltd, and Us Biomax Inc.
Key questions answered in this report:
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
Table of Contents
1. Executive Summary
2. List of Abbreviations
4. Research Methodology
5. Market Coverage
6. Market Landscape
6.1. Market Size and Forecast by Revenue
6.2. End-user Segmentation
6.3. Product Segmentation
6.4. Five Force Analysis
7. Geographical Segmentation
8. Key Leading Countries
9. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Key Vendor Analysis
16.1. Affymetrix Inc.
16.1.1. Business Overview
16.1.2. Key Information
16.1.3. SWOT Analysis
16.2. Illumina, Inc.
16.2.1. Business Overview
16.2.2. Key Information
16.2.3. SWOT Analysis
16.3. Agilent Technologies Inc.
16.3.1. Business Overview
16.3.2. Key Information
16.3.3. SWOT Analysis
16.4. GE Healthcare Ltd.
16.4.1. Business Overview
16.4.2. SWOT Analysis
17. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Biochips Market 2012-2016 (US$ billion)
Exhibit 2: Global Biochips Market by End-user Segmentation 2012
Exhibit 3: Global Biochips Market by Product Segmentation 2012
Exhibit 4: Global Biochips Market by Geographic Segmentation 2012
Affymetrix Inc., Illumina, Inc., GE Healthcare Ltd.,Agilent Technologies Inc.,Bio-Rad Laboratories Inc., Biomrieux Sa, Caliper Life Sciences Inc., Cephied Inc., Fluidigm Corp., Life Technologies Corp., Cybrdi Inc., Gamida For Life Group, Origene Technologies Inc., Perkinelmer Inc., Roche Nimblegen Inc., Sigma Aldrich Corp, Isu Abxis Co. Ltd, and Us Biomax Inc.
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001